Search results

Articles (4)

Journals (0)

1-4 of 4 results for half dose rt-PA

Sort by:

Relevance

Select all

Sort by:

Relevance

Restricted accessResearch articleFirst published January, 2014

Half-Dose Recombinant Tissue Plasminogen Activator Treatment in Venous Thromboembolism

H. Canan Hasanoğlu, Habibe Hezer, Ayşegül Karalezli [...]

Journal of Investigative Medicine

Open accessResearch articleFirst published December, 2021

Low-dose thrombolysis for submassive pulmonary embolism

Emine Serap Yilmaz, Oğuz Uzun

Journal of Investigative Medicine

Restricted accessResearch articleFirst published November, 2005

Prohemorrhagic and Bleeding Time Activities of Recombinant Tissue Plasminogen Activator,Heparin,Aspirin,and a Glycoprotein IIb/IIIa Antagonist

Kayoko Mihara, Toshiaki Aoki, Akira Moriguchi [...]

Journal of Neurotrauma

Open accessResearch articleFirst published August, 2011

Statistical aspects of the TNK-S2B trial of tenecteplase versus alteplase in acute ischemic stroke: an efficient,dose-adaptive,seamless phase II/III design

Bruce Levin, John LP Thompson, Bibhas Chakraborty [...]

Clinical Trials

Search results

Articles (4)

Journals (0)

1-4 of 4 results for half dose rt-PA

Sort by:

Relevance

Select all

Sort by:

Relevance

Restricted accessResearch articleFirst published January, 2014

Half-Dose Recombinant Tissue Plasminogen Activator Treatment in Venous Thromboembolism

H. Canan Hasanoğlu, Habibe Hezer, Ayşegül Karalezli [...]

Journal of Investigative Medicine

Open accessResearch articleFirst published December, 2021

Low-dose thrombolysis for submassive pulmonary embolism

Emine Serap Yilmaz, Oğuz Uzun

Journal of Investigative Medicine

Restricted accessResearch articleFirst published November, 2005

Prohemorrhagic and Bleeding Time Activities of Recombinant Tissue Plasminogen Activator,Heparin,Aspirin,and a Glycoprotein IIb/IIIa Antagonist

Kayoko Mihara, Toshiaki Aoki, Akira Moriguchi [...]

Journal of Neurotrauma

Open accessResearch articleFirst published August, 2011

Statistical aspects of the TNK-S2B trial of tenecteplase versus alteplase in acute ischemic stroke: an efficient,dose-adaptive,seamless phase II/III design

Bruce Levin, John LP Thompson, Bibhas Chakraborty [...]

Clinical Trials